Delivery Order SPE2DB22D1202-SPE2DB25FVCY5

Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DICLOFENAC POT 50 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price of $3,543.11 and a completion date of May 27, 2025. This appears to be a delivery order contract, not associated with a larger contract vehicle. The contract is not set aside for any specific...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Voltaren Arthritis Pain 1% Gel in 100 gram units. The delivery order, valued at $1,145.00, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,097.14, is for the delivery of Voltaren Arthritis Pain 1% Gel in 100-gram tubes. The contract has a completion date of January 29, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $8,857.56 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4,557,985,673 units of the prescription drug Diclofenac Potassium 50 mg tablets in 100-count bottles. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DICLOFENAC-MISOPROST 75-0.2 MG 60S, a pharmaceutical product, with a ceiling value of $2,161.04 and a period of performance through April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of Voltaren Arthritis Pain 1% Gel, a prescription topical pain medication, valued at $1,261.49. The contract has a period of performance through September 19, 2024 and is a firm fixed-price type. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty-one thousand six hundred sixty dollars to Amerisourcebergen Drug Corporation for Diclofenac Sodium 1% Gel 100gm. The single day contract has a period of performance from August 7 through August 8, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for a topical nonsteroidal...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,965.49 contract is for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, and pain management, as well as specialized medical supplies. The contract has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $101,524.70 firm fixed-price contract is for the delivery of a variety of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract has an ultimate completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,508.13 and a performance period through May 2025. It is a firm fixed-price contract for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FVCY5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of diclofenac sodium 1% gel in 100 gram quantities. The contract has a firm fixed price of $1,522.95 and a completion date of June 25, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order contract is part of the company's broader support for federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/28/25, 2:06 AM